News

News

10 July 2018: Sysmex Establishes Subsidiary in Egypt and Begins Conducting Direct Sales and Services

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) has established a new subsidiary in Egypt and will begin conducting direct sales and services with the aim of expanding its business in the Middle East.

27 June 2018: Sysmex, the Foundation for Biomedical Research and Innovation at Kobe, and Kyoto University Begin Joint Research on Technologies for Diagnosing Immunological Diseases

Sysmex Corporation (HQ: Kobe, Japan: Chairman and CEO: Hisashi Ietsugu), the Foundation for Biomedical Research and Innovation at Kobe1 (Location: Kobe, Japan; President: Tasuku Honjo) and Kyoto University (Location: Kyoto, Japan; President: Juichi Yamagiwa) have begun joint research related to the Drug Discovery Innovation Program: Developing Technologies for Diagnosing Immunological Diseases, which the Foundation is promoting. Through joint research, the three organizations aim to create a diagnostic system that will enable the early detection of autoimmune disease and chronic inflammatory disease.

11 May 2018: Sysmex launches the Gene Amplification Detector RD-200 and LYNOAMP™CK19 gene-amplification reagent for testing of cancer lymph node metastasis using the OSNA™ method

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) announces the launch of the Gene Amplification Detector RD-200 and the LYNOAMP™CK19 gene-amplification reagent, new products in its system for the rapid detection of cancer lymph node metastasis using the OSNA™ method1 developed by the Company. We will launch these products in Japan and plan a gradual rollout to other markets. By providing a new system with an enhanced sample processing capacity, we aim to promote the further popularization of the detection of cancer lymph node metastasis using the OSNA™ method, as well as contributing to the standardization of healthcare.

10 May 2018: Sysmex to Establish Bio-Diagnostic Reagent Center

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) announces plans to establish the Bio-Diagnostic Reagent Center to boost the Company’s competitiveness and provide a stable supply of “diagnostic reagents using proteins and substances derived from living organisms” (bio-diagnostic reagents) by handling the integrated process from procurement of substances, and the development, production to distribution of bio-diagnostic reagents. Through this facility, Sysmex aims to expand its activities related to the fields of hemostasis, immunochemistry, life science and others.

02 May 2018: Sysmex Employee to Receive “Medal with Purple Ribbon,” a Spring 2018 Medal of Honor

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) employee Junya Inoue has been selected to receive the Medal with Purple Ribbon, medals of honor to be bestowed in spring 2018, for the development of an automated urinalysis analyzer using flow cytometry technology1. The award ceremony and ceremony of imperial conferment is scheduled for Tuesday, May 15, 2018.

26 April 2018: Sysmex to Launch JICA Project in the Republic of Ghana – “Collaboration Program for Disseminating Automated Urinalysis Diagnosis Technology”

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) responded to a call by the Japan International Cooperation Agency (JICA) for proposals under the second fiscal 2017 Collaboration Program with the Private Sector for Disseminating Japanese Technology for Social and Economic Development of Developing Countries. Sysmex’s proposal “Dissemination of Automated Urinalysis Diagnosis technology in the Republic of Ghana” was selected.

25 April 2018: Sysmex Obtains Certification under ISO Guide 34, the International Standard for the Competence of Reference Material Producers

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) announces its accreditation under the international standard ISO Guide 34 (General requirements for the competence of reference material producers). It is important for laboratories to ensure traceability, in order to ensure the quality of their test results. Laboratories ensure traceability through routine calibration and quality control. The standard materials used in this calibration are referred to as “reference materials.” Certification under ISO Guide 34 provides international verification that Sysmex possesses the technical competence to supply reference materials of an appropriate quality.

08 April 2018: Sysmex launches Caresphere,™ a new network solution supporting the intelligent use of information for the healthcare of the future

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) offers a new network solution, Caresphere,™ to provide new value through the intelligent use of information by people involved in testing and healthcare, with a view to accelerating the future use of information in healthcare. Caresphere™ creates an environment for linking and analyzing a variety of information from testing instruments and laboratory information systems1 in real time, seamlessly and safely in one platform. Through Caresphere,™ Sysmex will support the resolution from a new dimension of issues faced by customers around the world.

20 February 2018: Sysmex Celebrates Its 50th Anniversary

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) celebrated the 50th anniversary of its establishment on February 20, 2018. We offer our heartfelt appreciation for the support of our customers and all other stakeholders since the time of our establishment in 1968.

20 February 2018: FY2017 Nakatani Award and Research Grant Recipients Announced

The Tokyo-based Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering announced 2 recipients of The Nakatani Award, 38 recipients of its Technology Development Research Grants and 2 recipients of its Investigative Research Grants for fiscal 2017.